4AB:ETR
AbbVie Common Stock
€234.10
arrow_upward
+1.34%(+3.10) 1D
Oct 5, 5:35:35 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4AB...
Open
€234.80
High
€235.10
Low
€232.40
Mkt. cap
469.63B
Avg. vol.
664.00
Volume
347.00
52-wk high
€237.60
52-wk low
€162.85
No. of employees
57K
Open
€234.80
High
€235.10
Low
€232.40
Mkt. cap
469.63B
Avg. vol.
664.00
Volume
347.00
52-wk high
€237.60
52-wk low
€162.85
No. of employees
57K
News stories
From web sources and news partners
Reuters
·
3 hours ago
Genmab, AbbVie blood cancer drug combo cuts risk of progression or death in late-stage study
TradingView
·
3 hours ago
Abbvie - Q3 2026 GAAP And Adjusted Earnings Include $216 Million Bought Ipr&D And Milestones Expense - SEC Filing
GuruFocus
·
3 hours ago
AbbVie (ABBV) Flags $216M Q3 Charge Impacting Earnings Amid Divi
Yahoo Finance Singapore
·
4 hours ago
Why AbbVie (ABBV) Outpaced the Stock Market Today
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57K
FoundedApr 10, 2012
HeadquartersNorth Chicago, Illinois, United States
SectorBiotechnology
Websiteabbvie.com